BIOMAT Database Logo BIOMAT Database Logo

[Neurochemical aspects and pharmacological implications in essential tremor (preliminary note)]. 1977

F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010525 Peripheral Nerves The nerves outside of the brain and spinal cord, including the autonomic, cranial, and spinal nerves. Peripheral nerves contain non-neuronal cells and connective tissue as well as axons. The connective tissue layers include, from the outside to the inside, the epineurium, the perineurium, and the endoneurium. Endoneurium,Epineurium,Perineurium,Endoneuriums,Epineuriums,Nerve, Peripheral,Nerves, Peripheral,Perineuriums,Peripheral Nerve
D011395 Promazine A phenothiazine with actions similar to CHLORPROMAZINE but with less antipsychotic activity. It is primarily used in short-term treatment of disturbed behavior and as an antiemetic. Promazine Hydrochloride,Protactyl,Sinophenin,Sparine,Hydrochloride, Promazine
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002230 Carbidopa An inhibitor of DOPA DECARBOXYLASE that prevents conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no anti-parkinson activity by itself. Methyldopahydrazine,Carbidopa, (R)-Isomer,Carbidopa, (S)-Isomer,Lodosin,Lodosyn,MK-485,MK-486,MK 485,MK 486,MK485,MK486
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D006220 Haloperidol A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279) Haldol

Related Publications

F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
[Neurochemical aspects of Parkinson tremor].
April 1979, La Clinica terapeutica,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
[Neurochemical treatment of Parkinson's disease and essential tremor].
January 2004, Revista de neurologia,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
[The essence of essential tremor: neurochemical bases].
June 2016, Revista de neurologia,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
Pharmacological and neurochemical aspects of kindling.
January 1985, Journal of neural transmission,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
Pharmacological management of essential tremor.
December 2010, Drugs,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
Linking Essential Tremor to the Cerebellum: Neurochemical Evidence.
June 2016, Cerebellum (London, England),
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
Pharmacological aspects of memory neurochemical regulation.
January 1982, Acta physiologica et pharmacologica Bulgarica,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
The pharmacological management of essential tremor.
January 1986, Clinical neuropharmacology,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
[Epidemiologic aspects of essential tremor].
January 1985, Archivos de neurobiologia,
F Piccoli, and M P Smorto, and D Raimondo, and B Fierro, and G G Vinci, and I Lupo, and L Pastore, and O Daniele
Neurochemical and pharmacological aspects of cocaine-induced seizures.
January 2001, Polish journal of pharmacology,
Copied contents to your clipboard!